Accession Number : ADA188226

Title :   Army Drug Development Program. Phase 1. Clinical Testing.

Descriptive Note : Final rept. 19 Aug 83-20 Apr 84,

Corporate Author : BIO-MED INC GAMBRILLS MD

Personal Author(s) : Reba, Richard C ; Barry, Kevin G

PDF Url : ADA188226

Report Date : Apr 1985

Pagination or Media Count : 7

Abstract : This is the final report of contract DAMD17-83-C-3001 under which BIO-MED, Inc. was involved in the following activities: The development of protocols for Phase I Clinical Studies and the administrative and technical processing of these protocols. Analysis, interpretation and reporting of the results of studies. Keywords: Pharmacokinetics, Anti-Malarials, Pyridostigmine, Abate, WR 194,965, Acetylcholinesterase Assays, WR 6026.

Descriptors :   *PHARMACOKINETICS, *ANTIMALARIALS, ACETYLCHOLINESTERASE, ARMY, CLINICAL MEDICINE, DRUGS, MANAGEMENT, PHASE STUDIES, PROCESSING, TEST AND EVALUATION, BIOASSAY

Subject Categories : Pharmacology

Distribution Statement : APPROVED FOR PUBLIC RELEASE